Eisenberg Glenn A 的 Form 4 申報
Labcorp Holdings Inc.（LH），2024/8/19 申報
- 申報編號
- 0001127602-24-022401
- 申報時間
- 2024/8/19
- 交易日
- 2024/8/15
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $336.0 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Eisenberg Glenn ACIK 0001222831 | 高階主管（財務長、執行副總裁） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The price of $222.6494 per share represents a weighted average of sales prices ranging from $222.25 to $223.15 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The price of $223.6169 per share represents a weighted average of sales prices ranging from $223.25 to $224.162 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price of $224.5488 per share represents a weighted average of sales prices ranging from $224.25 to $224.91 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
備註
On May 17, 2024, Labcorp Holdings Inc. ("LHI") became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.